Global capsule leader CapitalsCanada, now Lyfe Group, serves pharmaceutical and nutraceutical markets across more than 60 regions with expertise in gelatin and HPMC capsules, signaling growth opportunities with global manufacturers seeking reliable supply and regulatory support.

Family-owned stability As a three-generation family-owned business with a long-standing focus on quality and personalized service, there is potential to position Lyfe Group as a trusted partner for long-term capsule supply agreements and collaborative development projects.

Expansion readiness Recent activity and participation in industry events like DCAT Week highlight readiness to expand partnerships, offering sales opportunities in formulation development, manufacturing optimization, and market strategy consulting for hard capsule programs.

Technology enablement Investments in modern tech stack and regulatory/compliance capabilities can be leveraged to offer customers seamless integration, data-driven productivity improvements, and robust support for filling machine compatibility.

Financial foothold With a revenue range of 25 to 50 million and a demonstrated track record across global markets, Lyfe Group presents a viable target for scale-up collaborations, capacity expansion projects, and strategic partnerships with mid-size pharma manufacturers seeking dependable capsule supply.